| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-08 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-05 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 3e-05 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.15 | 7e-05 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |